Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides.
Angiotensin II (Ang II) is known to induce cardiomyocyte hypertrophy by activating the Ang II type 1 (AT1) receptor. Some studies have demonstrated that the autoantibodies against angiotensin AT1 receptor (AT1-AAs) cause functional effects, which is similar to those observed for the natural agonist Ang II. In this study, we investigated the effects of AT1-AAs on cardiomyocytes' structure and function. Male Wistar rats were immunized with synthetic peptides corresponding to the second extracellular loop of AT1 receptor and Freund's adjuvant. The titers of AT1-AAs in rat serum were detected by enzyme-linked immunosorbent assay every week. Hemodynamic analysis and heart weight (HW) indices were measured on the 4th and 8th months after initial immunization, respectively. Cultured neonatal rat cardiomyocytes were used to observe the hypertrophic effects of AT1-AAs. Results showed that systolic blood pressure and heart rate were significantly increased, the titers of AT1-AAs were also increased after 4 weeks of initial immunization. Compared with control group, the HW/body weight (BW) and left ventricular weight/BW of immunized rats were increased significantly and cardiac function was enhanced compensatively. The cultured neonatal rat cardiomyocytes respond to AT1-AAs stimulation with increased (3)H-leucine incorporation and cell surface area in a dose-dependent manner. These results suggest that the AT1-AAs have an agonist effect similar to Ang II in hypertrophy of cardiomyocytes in vivo and in vitro. AT1-AAs are involved in the pathogenesis of cardiovascular diseases and hypertension.
Department of Physiology, Shanghai Jiao Tong University, School of Medicine, China.
Zhu
Z
Jin
Jin
J
Wang
Wenhui
W
Zhang
Guohua
G
Zhang
Xiangying
X
Jiao
Jianming
J
Zhi
D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001323:Autoantibodies / Q000097:blood* / Q000276:immunology; D001794:Blood Pressure / Q000187:drug effects; D006332:Cardiomegaly; D049108:Cell Enlargement / Q000187:drug effects*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar / Q000276:immunology*; D044140:Receptor, Angiotensin, Type 1 / Q000008:administration & dosage* / Q000276:immunology / Q000378:metabolism*
D001323:Autoantibodies; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II